We analysed the haemodynamic, metabolic and hormonal status at rest and in response to exercise, in young normotensive women with two hypertensive parents (FH þ þ ; n ¼ 17; 25.1±4.8 years), one hypertensive parent (FH þ ; n ¼ 18; 24.9 ± 4.1 years) and normotensive parents (FHÀ; n ¼ 15; 25.3 ± 3.8 years). Casual and ambulatorial blood pressure (BP), carotid-femoral pulse wave velocity (PWV) and biochemistry were analysed. BP, nor-epinephrine (NE), epinephrine (EPI), endothelin-1 (ET-1) and nitrite/nitrate (NOx) levels were also analysed during a graded exercise test (GXT). Casual and ambulatorial BP were not different between groups, but PWV was 7.5 and 12.6% higher in FH þ þ than FH þ and FHÀ, respectively, and 4.8% higher in FH þ than FHÀ (Pp0.01). Insulin and insulin-to-glucose ratio were increased in FH þ þ and FH þ (Po0.05), and lowdensity lipoprotein (LDL)-cholesterol tended to be higher only in FH þ þ (P ¼ 0.07). FH þ þ showed higher exercise and recovery diastolic BP and EPI levels, and increased resting, exercise and recovery NE, and ET-1 levels than FHÀ (Po0.05). FH þ showed only greater resting, exercise and recovery NE, and rest ET-1 (Po0.05). Resting, exercise and recovery NOx were lower in FH þ þ and FH þ than FHÀ (Po0.01). Haemodynamic, metabolic and hormonal abnormalities were presented in nonhypertensive young women offspring of hypertensive parents before any increase in BP. Greater abnormalities were observed in women with a strong family history of hypertension (FH þ þ ). These results suggest that there is an early vascular, metabolic and hormonal involvement in a familial hypertensive disorder.
Introduction
Essential arterial hypertension is the most common risk factor for cardiovascular morbidity and mortality, and is associated with substantial health care expenditure. 1, 2 Consequently, primary prevention in individuals at high risk for hypertension has been emphasized. 3 Among the population at high risk for hypertension, those who have hypertensive parents are worthy of special attention. It is well-established that positive family history of hypertension is a strong risk factor for future hypertension in nonhypertensive offspring, which is independent of other risk factors. 4, 5 Moreover, haemodynamic and metabolic abnormalities, as well as concentrations of biomarkers that may have a role in the development of hypertension are increased in nonhypertensive offspring of parents with hypertension. [6] [7] [8] Despite the large number of family history of hypertension researches, the underlying pathophysiology of family cluster hypertension is incompletely understood. Further, studies investigating the possible mechanisms involved in the pathophysiology of family history of hypertension have demonstrated contradictory findings. For example, increased arterial stiffness in nonhypertensive offspring of hypertensive subjects have been shown in some [8] [9] [10] but not all studies. 11, 12 Also, increased sympathetic activity in response to mental 13 or physical 14 stress has been shown in normotensive offspring of hypertensive parents, but there are contradictory findings relating to resting sympathetic activity. 7, [15] [16] [17] [18] [19] There are some issues regarding the methodology of family history of hypertension investigations that may explain these contradictory results. First, the subject's family history is not always verified by parents or doctors.
Second, in most studies individuals with one and two hypertensive parents are generally combined and viewed as a single group, therefore, one cannot determine the extent to which haemodynamic, metabolic or hormonal abnormalities in positive family history subjects is influenced by including offspring of dual hypertensive parents. Third, as gender of offspring has shown to be a meaningful factor in the risk associated with parental hypertension, 19 the practice of combining the genders masks the fact that parental hypertension may influence men and women differently. Finally, the reduced number of studies analyzing family history in women does not control female hormonal status, a factor that may affect haemodynamic response to stress. 20 Therefore, to clarify the 'real' haemodynamic, metabolic and hormonal abnormalities affecting nonhypertensive young women with positive family risk of hypertension, it seems to be crucial to eliminate the interacting effects of female hormones and number of hypertensive parents. 19, 20 This study focused on analyzing haemodynamic, metabolic and hormonal status in young normotensive women with two hypertensive parents, one hypertensive parent and normotensive parents.
Methods

Subjects
We studied 50 healthy young college women (19-30 years) with two hypertensive parents (FH þ þ ), one hypertensive parent (FH þ ) or normotensive parents (FHÀ). All women had blood pressure (BP) below 130/80 mm Hg (obtained by measurements on two different occasions on triplicate at 2-min intervals), and had regular menstrual cycle (determined by menstrual assessment charts completed for 3 consecutive months before participation). Positive family history of hypertension was defined as treatment for essential hypertension (stage 1 or 2) for at least 2 years confirmed by records of the parents' physicians. Negative family history of hypertension was defined as the absence of any evidence for essential hypertension (BP below 130/ 85 mm Hg) or history of cardiovascular disease in both parents, confirmed by a questionnaire sent to the parents, by records of the parents' physicians and by measure of parents' BP (measurements on two different occasions in triplicate at 2-min intervals). Exclusion criteria included age 430 years, use of medication, presence of any kind of disease (based on history, medical examination and exercise stress testing) and smoking. Pregnancy or lactation, and involvement in regular physical activity or exercise programme during the previous 12 months were also exclusion criteria. After a detailed explanation of the study design and protocol, written informed consent was obtained from each subject before participation as approved by the ethics committee at our institution.
Following a 12 h overnight fast, subjects had their weight, height and waist circumference determined. After being seated for at least 5 min, venous blood was taken for analyses of insulin, glucose, lipids and estradiol. Between 1400 and 1500 hours of the day after the first visit, subjects had their BP and pulse rate determined by three measurements with 2-min intervals and after a 15-min seated rest. Carotidfemoral pulse wave velocity (PWV) was then measured, and a 24-h ambulatory BP monitoring initiated at the end of this visit. Two days after the second visit (between 0800 and 1100 hours), a maximal graded exercise test (GXT) with blood sampling for catecholamine, endothelin-1 (ET-1) and nitrite/nitrate (NOx) analyses was carried out. All measurements were carried out in a quiet air-conditioned (21-24 1C) room, during the follicular phase (days 2 through 8) of the volunteers' menstrual cycle, which was confirmed by serum estradiol analysis.
Ambulatory BP monitoring
We used a Spacelab 9207 device (Spacelabs Medical, Redmond, WA, USA) to evaluate 24-h ambulatory BP. BP was recorded at 15-min intervals during the day and 20-min intervals at night. The averages of the 24-h, daytime and nighttime systolic and diastolic BP were analysed.
PWV
Volunteers were asked to refrain from strenuous physical activities and caffeine or alcohol content beverages for 24 h, and having a light meal up to 3 h before the test. Carotid-femoral PWV was analysed with a noninvasive automatic device (Complior; Colson; Garges les Gonesses, France) by an experienced observer blinded to the subjects' clinical characteristics. Briefly, common carotid artery and femoral artery pressure waveforms were recorded noninvasively using a pressure-sensitive transducer (TY-306-Fukuda; Fukuda, Tokyo, Japan). The distance between the recording sites (D) was measured in a straight line with a flexible metre, and PWV was automatically calculated as PWV ¼ D/t, where (t) means pulse transit time. 21 Measurements were repeated over 10 different cardiac cycles, and the mean was used for the final analysis.
Exercise testing
Volunteers were asked to refrain from strenuous physical activities and caffeine or alcohol-content beverages for 24 h before the GXT. As plasma NOx levels can be influenced by diet, 22 volunteers were also asked to follow a low NOx diet for 5 days before the GXT. Subjects' last meal was ingested at least 4 h before beginning the GXT. Testing was carried at morning (between 0900 and 1200 hours) and after 1 h of rest in the supine position. A 20-G elastic tube was inserted into the antecubital vein before the beginning of resting period. Blood sampling was carried out at the end of resting period (resting), immediately after GXT (exercise) and 10 min after cessation of GXT (recovery) to evaluate plasma catecholamine, ET-1 and NOx levels. GXT was carried out on a programmable treadmill (TMX425 Stress Treadmill; TrackMaster; Newton, KS, USA) in a temperature-controlled room (21-23 1C) with a ramp protocol until exhaustion. Cardiac rythim was continuously monitored with a 12 lead electrocardiogram system (CardioSoft 6.5; GE Medical Systems IT; Milwaukee, WI, USA). BP monitoring was carried out by an automated device (Tango Stress BP; SunTech Medical, Morrisville, NC, USA). Minute ventilation (VE), oxygen uptake (VO 2 ), carbon dioxide output (VCO 2 ) and other cardiopulmonary variables were acquired breath-by-breath by a computerized system (Vmax Encore29; SensorMedics, Yorba Linda, CA, USA). The respiratory exchange ratios were recorded as the averaged samples obtained during each stage of the protocol. The highest VO 2 uptake level was considered the peak value (VO 2PEAK ).
Biochemical assays
All blood samples were immediately placed on ice, centrifuged at 2000 r.p.m. for 15 min at 4 1C, and plasma and serum were stored at À80 1C until assayed. Serum glucose, total cholesterol and fractions, and triglycerides were analysed by standard methods using a Dimension RXL Max automatic analyser (Dade Behring, Newark, DE, USA). Serum insulin was assayed by radioimmunoassay using human insulin-specific RIA kit (Linco Research, St Charles, MO, USA). Estradiol was determined by chemiluminescent immunoassay (Immulite, Diagnostic Products, Los Angeles, CA, USA). ET-1 was extracted from plasma with an Amprep C2 cartridge (Amersham Biosciences; Little Chalfont, Buckinghamshire, UK) and measured by radioimmunoassay using a commercially available ET-1 radioimmunoassay kit (ET-1,2 high sensitivy RIA kit, Institute of Isotopes, Budapest, Hungary). Plasma NOx levels were measured by spectrophotometry using a commercially available kit (colorimetric nitric oxide assay kit; Calbiochem, San Diego, CA, USA), according to the method described by Green et al 23 Catecholamines were extracted from plasma by aluminium oxide, and measured by high-performance liquid chromatography.
Statistical analysis
Data are reported as means±standard deviation or 95% confidence interval (CI). The statistical programme SPSS 12.0 for Windows (SPSS, Chicago, IL, USA) was used to carry out the statistical analysis. The Kolmogorov-Smirnov test was applied to ensure a Gaussian distribution of the data. Oneway analysis of variance was used to indicate differences among groups in the variables following a Gaussian distribution, and Bonferroni post-hoc analysis was used to identify significant group differences that were indicated by one-way analysis of variance. Kruskal-Wallis test was used to indicate differences among groups in the variables that did not follow a Gaussian distribution, and MannWhitney post-hoc test was used to identify significant group differences that were indicated by Kruskal-Wallis. Statistical significance was set at Po0.05.
Results
Demographic and BP measurements
Participants' characteristics are displayed at Table 1 . In all, 17 women were FH þ þ , 18 were FH þ and 15 were FHÀ. There were no significant differences for age, body mass index (BMI), waist circumference, and casual and ambulatory BP among the three family history of hypertension groups. The parents' age was similar among groups, and the drug regimen of the hypertensive parents was similar between FH þ þ and FH þ . Lipids, glucose and insulin assays Although total and high-density lipoprotein-cholesterol, triglycerides, and glucose were similar between groups, FH þ þ and FH þ groups showed significant higher insulin and insulin-to-glucose ratio (Po0.05) compared with those of the FHÀ group, whereas low-density lipoprotein-cholesterol showed a tendency to be higher (P ¼ 0.07) in FH þ þ than in FHÀ group (Table 2) .
PWV
Pulse wave velocity were 7.5% (Po0.01) and 12.6% (Po0.001) higher in the FH þ þ group compared with that of the FH þ and FHÀ group, respectively ( Figure 1 ). FH þ group also showed higher PWV (Po0.01) compared with that of the FHÀ group ( Figure 1 ).
Exercise stress response
The haemodynamic and ventilatory measurements are displayed in Table 3 . The three family history of hypertension groups were similar for cardiorespiratory fitness (VO 2PEAK ) and respiratory exchange ratio. The three groups also displayed a similar behaviour of systolic BP and HR across the GXT. However, diastolic BP behaviour was different. Although both FH þ þ , FH þ and FHÀ groups started GXT with similar diastolic BP levels, this variable increased B4.2 and B3.2 mm Hg at the end of GXT in the FH þ þ and FH þ , respectively, but reduced B2.6 mm Hg in the FHÀ group. With this diastolic BP hyperreactive response, FH þ þ showed increased peak diastolic BP levels compared with that of the FHÀ group (Po0.01), and increased recovery diastolic BP levels compared with FH þ and FHÀ groups (Po0.05). FH þ þ also showed increased levels of resting, exercise and recovery nor-epinephrine (NE; Po0.001), exercise Figures  2 and 3) . The recovery EPI level was also higher in the FH þ þ compared with that of FH þ (Po0.05).
In the FH þ , only resting, exercise and recovery NE (Po0.05), exercise EPI (Po0.01) and resting ET-1 (Po0.01) were greater, whereas resting, exercise and recovery NOx were lower (Po0.01) compared with FHÀ (Figures 2 and 3) . In addition to the greater plasma NE and EPI levels across the three phases of GXT (resting, exercise and recovery), a greater increase of NE and EPI during the exercise (Po0.01) was observed in the FH þ þ (NE: CI 1541.7-2053.6 pg ml À1 ; EPI: CI 65.4-359.5 pg ml À1 ) compared with that of the FHÀ group (NE: CI 849.7-1441.1 pg ml À1 ; EPI: CI 0.6-71.3 pg ml À1 ). There was no significant difference in the NE and EPI exercise increase between FH þ (NE: CI 1252.9-1782.2 pg ml À1 ; EPI: CI 71.1-197.5 pg ml À1 ) and FHÀ.
Discussion
The primary findings of this study were that nonhypertensive young women offspring of hypertensive parents had: (1) higher PWV, fasting insulin and insulin-to-glucose ratio; (2) higher BP response to exercise; and (3) altered catecholamine, ET-1 and NOx response to exercise, when compared with those of young nonhypertensive women offspring of nonhypertensive parents, that were matched for age, hormonal status, BMI, casual BP, ambulatory BP and fitness levels. Further, this study also showed that women with a strong family history of hypertension (two hypertensive parents) showed increased PWV, and higher diastolic BP, ET-1 and EPI response to exercise than women with one hypertensive parent. Despite the large number of family history of hypertension researches, to our knowledge this is the first study addressed to analyzing haemodynamic, metabolic and hormonal status in young normotensive women offspring of hypertensive parents that was intentionally designed to minimize the effect of menstrual cycle phase and number of hypertensive parents, two potentially confounding factors for the variables and population studied. 5, 19, 20 As a substantially higher risk in hypertension onset, especially at a younger age, was observed in male offspring with the early onset of parental hypertension, 5 one could argue that the age of parents when parental hypertension was first diagnosed may influence the results of this study. However, there was no significant difference in parents' age of first diagnosis of hypertension between groups.
Lipids, glucose and insulin
The existence of early abnormalities of glucose and insulin metabolism among offsprings of hypertensive parents has been confirmed by some investigators, 7, 19, [24] [25] [26] although not by all. 15, 27 Previous studies have shown elevated fasting insulin and insulin-to- Early abnormalities in family hypertension EG Ciolac et al glucose levels, as well as reduced sensitivity of insulin-mediated cellular glucose disposal, in normotensive offspring of hypertensive parents; however, data have not been analysed separately by neither gender nor parental burden. 7, [24] [25] [26] The only study we have known that assayed fasting insulin and insulin resistance in normotensive with three different parental hypertension burden showed that normotensive offspring of two hypertensive parents had elevated plasma insulin levels and were more likely to show greater insulin resistance than normotensive individuals having either one hypertensive parent or normotensive parents; however, the data were also not analysed separately by gender. 19 This study demonstrated that insulin and insulin-toglucose ratio (a marker of insulin resistance) were higher in both women with two or one hypertensive parents than in women with normotensive parents, when a population of young normotensive women matched for age, menstrual cycle phase, BMI and BP levels were analysed.
In addition, this study has also demonstrated that women with a strong family history of hypertension (two hypertensive parents) showed a tendency (P ¼ 0.07) to have greater low-density lipoproteincholesterol levels than women with normotensive parents. Because of the small sample size, the higher low-density lipoprotein-cholesterol levels observed in FH þ þ group, as well as observed in the FH þ group (B18 mg 100 ml À1 ), cannot be dismissed because of the absence of statistical significance, and may have important clinical relevance. Higher low-density lipoprotein-cholesterol levels among normotensive offsprings of hypertensive parents compared with normotensive with normotensive parents have been shown by some investigators, 7, 19, 24, 25, 28 although negative finds exist. 18, 26 Abnormalities in lipids, glucose and insulin metabolism have been found to be part of a complex of cardiovascular risk factors commonly found in hypertensive subjects. 29 Previous studies have shown that early stages of both insulin and lipid metabolism alterations are present in young normotensive offspring of hypertensive parents that are matched for gender, age and BMI but not for BP levels. 7, 19, 24, 25, 28 This study showed that these early insulin and metabolism alterations also occur in young normotensive female offsprings of hypertensive parents before any increase in BP levels.
PWV
A key finding of this study was that PWV was significantly higher in normotensive women offspring of two hypertensive parents when compared with both women with one hypertensive parent or normotensive parents. To our knowledge there are six studies dealing with large artery properties in young subjects at familial risk of hypertension, which have studied populations of different ages (10-71 years), used different methodologies and reported discrepant results. [8] [9] [10] [11] [12] 30 Higher carotid but not aortic stiffness was displayed in young (aged 10-20 years) offspring of hypertensive parents than in offspring of normotensive parents; however, the comparisons were not adjusted for neither BP (which was already higher in the offspring of hypertensive group) nor gender. 9 Central and peripheral pulse pressure, and central augmentation index (but not brachial PWV) were higher in offspring with hypertensive parents than in the offspring of normotensive parents (mean age 43 years); however, this study failed to show significant differences between women with positive and negative parental history of hypertension when data were analysed separately by gender. 11 The only study analyzing arterial stiffness in normotensive with three different parental hypertension burden, that were matched for age but not for gender and BMI, reported higher PWV and central augmentation index in subjects with one or both hypertensive parents, and subjects with both hypertensive parents displayed higher arterial stiffness indices than subjects with one hypertensive parent; however, the results were not analysed separately by gender. 30 Several factors such as differences in the methodology used to measure arterial stiffness, use of resting occasional measurements vs 24-h ambulatory BP monitoring to determine BP levels, and criteria used to determine family history of hypertension may explain these discrepancies.
A longitudinal study examining 2512 subjects (aged 35-94 years) who were not hypertensive at baseline and were followed for 4 years, provided evidence that increased aortic stiffness precedes hypertension. 31 Aortic stiffness measured at baseline by means of echocardiographic technique predicted progression to hypertension in both genders, which is independent of age. The results were consistent for all the three aortic stiffness indexes used and for different BP parameters, and remained significant after adjustment for baseline BP, age and all other classic cardiovascular risk factors, suggesting that aortic wall properties are likely to have a role in the pathogenesis of hypertension already in its early stages. Despite its cross-sectional design, this study adds to the longitudinal study 31 showing that an increase in arterial stiffness occurred in young normotensive women offspring of hypertensive parents before any increase in casual and ambulatory BP levels, with greater increases being observed in the women with a strong family history of hypertension (two hypertensive parents). However, the relationship of BP and arterial properties seems to be reciprocal, as that childhood BP predicted arterial stiffness assessed, on average, 26.5 years later by brachial-ankle PWV. 32 Exercise stress response Several prospective studies have shown that an exaggerated BP response to exercise is a predictor of future hypertension. [33] [34] [35] Although negative finds exist, 36, 37 some investigators have shown a greater BP response to exercise among normotensive offsprings of hypertensive parents compared with normotensive with normotensive parents. [38] [39] [40] However, almost all of the previous investigations analyzing exercise BP response among offspring of hypertensive parents have studied men 36, 38, 39 or have displayed its results by combining the genders. 40 The only study we know that analysed BP response to exercise in young normotensive women offspring of hypertensive parents failed to show any difference in BP response to exercise between positive and negative family history of hypertensive groups. 37 In contrast, although no significant difference was found between FH þ and FHÀ women, this study showed an increased diastolic BP response to exercise in FH þ þ compared with FHÀ women. Several methodological aspects may explain the differences between present and previous 37 studies. First, the present study analysed BP response during a GXT, whereas a low intensity (approximately 44% of VO 2PEAK ) submaximal exercise was carried out by the women of previous study. 37 Second, we confirm family history of hypertension by both checking physicians' records and measuring BP, but only physicians' records were used by previous study. 37 And third, we separately analysed women with one and two hypertensive parents, and found higher BP response to exercise only in women with two hypertensive parents; on the other hand, previous study analysed women with one and two hypertensive parents as a single group. 37 The most likely explanation to the increased BP response to exercise commonly found among normotensive offspring of hypertensive parents appears to be a failure to reduce total peripheral resistance. 40 Although the precise mechanism involved in this failure is not clearly understood, an increased activation of sympathetic nervous system may be a mechanism contributing to the exaggerated exercise BP, and may probably have a key role in the pathogenesis of essential hypertension. 13, 41, 42 Previous studies have shown that normotensive men offspring of hypertensive parents show increased sympathetic nervous system activity in response to mental stress, 13 hand grip exercise 41 and GXT. 42 This study demonstrates that young normotensive women offspring of hypertensive parents also have increased resting, exercise and recovery NE, and exercise and recovery EPI than women with normotensive parents. Moreover, in this study FH þ þ showed a greater increase in NE and EPI during the exercise compared with FHÀ, whereas FH þ displayed intermediate increases that were not statistically different from that observed in FHÀ, suggesting a greater impairment in the sympathetic activity in women with two hypertensive parents.
Besides the increased sympathetic nervous system activation, impaired endothelial vasodilator function may be another mechanism involved in the exaggerated BP response to exercise observed in this study. Higher exercise BP during a GTX has been associated with decreased endothelial vasodilator function in hypertensive men and women, 43 and several studies have shown that the basal release of endothelium-derived vasodilator nitric oxide is impaired in hypertensive subjects 44 and its normotensive offsprings. 45 Moreover, the levels of endothelium-derived vasoconstrictor ET-1 has shown to be increased in normotensive male offsprings of hypertensive parents during mental stress 13 and hand grip exercise. 41 In this study, we demonstrated for the first time an increase in ET-1 and decrease in NOx (metabolities of nitric oxide), during the basal, exercise and recovery phases of a GXT, in young normotensive women offspring of hypertensive parents, suggesting that the exaggerated exercise BP present in these women may be in part a function of an impaired endothelial vasodilator function.
Limitations
Although physical activity, cardiorespiratory fitness, waist circumference and BMI levels were controlled, information on other environmental factors associated with hypertension, such as sodium, potassium and fiber dietary intake, was not available. Therefore, our results do not allow us to estimate what portion of the haemodynamic, metabolic and hormonal abnormalities may be attributable to these lifestyle variables. Sympathetic activity was assessed indirectly by measuring plasma catecholamines. However, it is one of the preferred tests for analysing the acute effects of stress tests and give similar results as that observed with microneurography. 46 The marker NOx is a metabolite of nitric oxide and may not be the best measure of nitric oxide production/availability, because of the effects that diet may be on its measurement. However, the women were oriented to follow a low NOx diet for the 5 days preceding GXT, which has shown to minimize the effects of diet on NOx measurement. 22 Moreover, plasma NOx following GXT are related to endothelial function. 47 Clinical implication Cardiovascular disease remains the leading cause of death in most developed area of the world, 48 whereas ischaemic heart disease and stroke are the leading killers among women. 49 Extensive data indicate that the risk of death from ischaemic heart disease and stroke increases progressively and linearly with increasing BP in women and men. 2 This study demonstrated that nonhypertensive young women offspring of hypertensive parents, matched for age, menstrual cycle phase and BMI, displayed haemodynamic, metabolic and hormonal abnormalities, before any increase in the casual or ambulatory BP, and underscore the importance of differentiating between women with one or two hypertensive parents. These findings suggest that lifestyle modifications and a more focused health monitoring could be considered as prevention and early identification strategies. In this manner, it may prevent or delay the onset of high BP and therefore have large effect on public health. 48 In summary, this study showed early haemodynamic, metabolic and hormonal abnormalities in nonhypertensive young women offspring of hypertensive parents when compared with nonhypertensive women offspring of nonhypertensive parents. This study also showed that several of these abnormalities were increased in women with a strong family history of hypertension (two hypertensive parents), suggesting that there is an early vascular, metabolic and hormonal involvement in a familial hypertensive disorder.
What is known about this topic K Haemodynamic and metabolic abnormalities, and concentrations of biomarkers are increased in nonhypertensive male offsprings of parents with hypertension. K There are contradictory finds relating several of the previous cited abnormalities, and most of the abnormalities are explained by blood pressure (BP) status. K The profile of several hormonal, metabolic and haemodynamic variables, as well as the role of family history (one or two hypertensive parents), in young women with family history of hypertension is unknown.
What this study adds K Haemodynamic, metabolic and hormonal abnormalities, at rest and in response to exercise stress, were presented in nonhypertensive young female offsprings of hypertensive parents before any increase in BP. K Greater abnormalities were observed in women with a strong family history of hypertension (two hypertensive parents).
